AKT1 and ovarian cancer: Taken together, our data revealed that circPLEKHM3 inactivates the AKT1 and canonical Wnt/β-catenin signaling pathways by regulating the expression of BRCA1, DNAJB6 and KLF4 in ovarian cancer cells.